Drug intelligence / Profile preview

Singripal F

Development stage
Unknown
Lead developer
Farmayala Pharmaceutical Company
Modality
Small Molecules
Administration
Oral
01

Overview

Singripal F is a fixed-dose combination medication developed by Farmayala Pharmaceutical Company for the symptomatic relief of the common cold and influenza. It integrates four active pharmaceutical ingredients: paracetamol (acetaminophen), which provides analgesic and antipyretic effects; phenylephrine hydrochloride, a sympathomimetic amine that acts as a nasal decongestant; dextromethorphan hydrobromide, a non-opioid antitussive; and chlorpheniramine maleate, a first-generation antihistamine. The medication is formulated as granules in sachets for oral reconstitution and is primarily indicated for the treatment of cough, nasal congestion, rhinorrhea, sneezing, and general malaise. It is manufactured by INDEUREC S.A. and is currently marketed in Ecuador.

Brand names
Singripal F
02

Targets

ADRA1A (α1A)ADRB1 (β1)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Singripal F.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Singripal F.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call